Search

everythinglearnresearchcommunity

for

Search:↓

Liquid nitrogen cryotherapy worked well for many patients with stubborn alopecia areata.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Follicular unit extraction successfully restored hair growth in a leprosy patient without disease relapse.

Combination therapy is better for long-term control and outcomes in type 2 diabetes.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Women with PCOS have a similar chance of getting pregnant using assisted reproductive treatment as those without PCOS.

Combining PRP and microneedling effectively improves hair growth and patient satisfaction for hair loss.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

The new SFS Scale predicts hair transplant difficulty using hair and skin types, with thick skin and coily hair being hardest to work with.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Canakinumab's effect on COVID-19 outcomes is unclear.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Young adults who had liver disease as children often experience significant health problems and frequently need transplants.

Injecting platelet-rich plasma during hair transplant surgery improves hair regrowth rate, speeds up skin recovery, and enhances hair quality.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.